28,490 resources
By Version
By Authority
By Realm
Start Prev Rows 13600 - 13800 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
hl7.terminology | R5 | v3-ActEncounterCode | ActEncounterCode | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-DeviceAlertLevel | DeviceAlertLevel | active | 2014-03 | uv | hl7 | tho | ||
fhir.org.nz.ig.base | R4 | domicile-code | Domicile Code | active | 2025-06 | us | hl7 | |||
br.go.ses.core | R4 | dose-administrada-gestante | Dose Administrada Gestante | active | 2025-01 | br | ||||
smart.who.int.icvp | R4 | DoseNumber | Dose Number | draft | 2025-07 | who | internal | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7927 | Dose Unit (STD) | active | 2020-01 | us | ucum sct tho | |||
de.dktk.oncology | R4 | ValueSet-onco-core-ValueSet-StrahlentherapieeinheitVS | StrahlentherapieeinheitVS | active | ||||||
vzvz.fhir.mitz | R4B | dossierhoudendezorgaanbiedercategorie | Dossierhoudende zorgaanbiedercategorie ValueSet | draft | 2024-01 | |||||
hl7.terminology | R5 | v3-Douche | Douche | active | 2014-03 | uv | hl7 | tho | ||
nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.11.357--20220117103812 | Douchen_GZ | active | nl | sct | ||||
healthdata.be.r4.cbb | R4 | Dressing | Dressing | draft | oid | |||||
healthdata.be.r4.cbb | R4 | DressingOneself | DressingOneself | draft | sct | |||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.8.2--20200901000000 | DrinkBeperkingenCodelijst | active | nl | hl7 | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.8.2--20171231000000 | DrinkBeperkingenCodelijst | active | nl | sct | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.8.1--20200901000000 | DrinkenCodelijst | active | nl | hl7 | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.8.1--20171231000000 | DrinkenCodelijst | active | nl | sct | ||||
healthdata.be.r4.cbb | R4 | Drinking | Drinking | draft | sct | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7630 | Drinking Water (FDD) | active | 2017-01 | us | tho oid | |||
healthdata.be.r4.cbb | R4 | DrinkingLimitations | DrinkingLimitations | draft | sct | |||||
de.gevko.eahb | R4 | EAHBVSBefundBeeintraechtigungenLW | Alltagsrelevante Beeinträchtigungen - Lernen und Wissensanwendung | active | 2021-05 | |||||
de.gevko.eahb | R4 | EAHBVSBefundBeeintraechtigungenAA | Alltagsrelevante Beeinträchtigungen - Allgemeine Aufgaben | active | 2021-05 | |||||
de.gevko.eahb | R4 | EAHBVSBefundBeeintraechtigungenBLB | Alltagsrelevante Beeinträchtigungen - Bedeutende Lebensbereiche | active | 2021-05 | |||||
de.gevko.eahb | R4 | EAHBVSBefundBeeintraechtigungenKO | Alltagsrelevante Beeinträchtigungen - Kommunikation | active | 2021-05 | |||||
de.gevko.eahb | R4 | EAHBVSBefundBeeintraechtigungenMO | Alltagsrelevante Beeinträchtigungen - Mobilität | active | 2021-05 | |||||
de.gevko.eahb | R4 | EAHBVSBefundBeeintraechtigungenSV | Alltagsrelevante Beeinträchtigungen - Selbstversorgung | active | 2021-05 | |||||
de.gevko.eahb | R4 | EAHBVSBefundBeeintraechtigungenIIB | Alltagsrelevante Beeinträchtigungen - Interpersonelle Interaktionen und Beziehungen | active | 2021-05 | |||||
de.gevko.eahb | R4 | EAHBVSBefundBeeintraechtigungenHL | Alltagsrelevante Beeinträchtigungen - Häusliches Leben | active | 2021-05 | |||||
de.gevko.eahb | R4 | EAHBVSBefundBeeintraechtigungenGL | Alltagsrelevante Beeinträchtigungen - Gemeinschaftsleben | active | 2021-05 | |||||
ans.fr.nos | R4 | JDV-J216-DroitExerciceCompl-ROR | JDV_J216-DroitExerciceCompl-ROR | active | 2022-08 | fr | national | |||
MyHIE.v4-test | R4 | value-set-drug-my-core | ValueSetDrug (MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-drug-id-core | ValueSetDrug (ID Core) | active | 2023-06 | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1071 | Drug Susceptibility Test Result Name | active | 2008-01 | us | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1102 | Drug Active Ingredients | active | 2008-01 | us | oid | |||
MyHIE.v4-test | R4 | value-set-drug-allergy-my-core | ValueSetDrugAllergy (MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-drug-allergy-id-core | ValueSetDrugAllergy (ID Core) | active | 2023-06 | |||||
MyHIE.v4-test | R4 | value-set-drug-category-my-core | ValueSetDrugCategory (MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-drug-category-id-core | ValueSetDrugCategory (ID Core) | active | 2023-06 | |||||
MyHIE.v4-test | R4 | value-set-drug-cautionary-my-core | ValueSetDrugCautionary (MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-drug-cautionary-id-core | ValueSetDrugCautionary (ID Core) | active | 2023-06 | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1108 | Drug Classes (NDF-RT) | active | 2008-01 | us | tho | |||
MyHIE.v4-test | R4 | value-set-drug-dose-form-my-core | ValueSetDrugDoseForm (MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-drug-dose-form-id-core | ValueSetDrugDoseForm (ID Core) | active | 2023-06 | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1106 | Drug Manufacturers (NDC) | active | 2008-01 | us | ndc | |||
MyHIE.v4-test | R4 | value-set-drug-schedule-my-core | ValueSetDrugSchedule (MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-drug-schedule-id-core | ValueSetDrugSchedule (ID Core) | active | 2023-06 | |||||
MyHIE.v4-test | R4 | value-set-drug-sub-group-my-core | ValueSetDrugSubGroup (MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-drug-sub-group-id-core | ValueSetDrugSubGroup (ID Core) | active | 2023-06 | |||||
MyHIE.v4-test | R4 | value-set-drug-trade-name-my-core | ValueSetDrugTradeName (MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-drug-trade-name-id-core | ValueSetDrugTradeName (ID Core) | active | 2023-06 | |||||
MyHIE.v4-test | R4 | value-set-drug-type-my-core | ValueSetDrugType (MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-drug-type-id-core | ValueSetDrugType (ID Core) | active | 2023-06 | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7467 | Drug Disease Interaction (Dengue) | active | 2016-01 | us | sct | |||
ehealth4u.package | R4 | cyehr-vs-DrugOrMedicationType | Cyprus EHR Value Set: Drug Or Medication Type | active | sct tho | |||||
ehealth4u.package | R4 | cyehr-vs-DrugUseStatus | Cyprus EHR Value Set: Drug Use Status | active | sct tho | |||||
nictiz.fhir.nl.stu3.zib2015 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20150401000000 | DrugGebruikStatusCodelijst | retired | nl | sct | ||||
healthdata.be.r4.cbb | R4 | DrugUseStatus | DrugUseStatus | draft | sct | |||||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-drugs | Drugs | draft | 2025-03 | uv | hl7 | atc sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7055 | Antituberculosis Drugs (TB) | active | 2013-01 | us | rx | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20200901000000 | DrugsGebruikStatusCodelijst | active | nl | hl7 | sct tho | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20171231000000 | DrugsGebruikStatusCodelijst | active | nl | fhir sct | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20200901000000 | DrugsOfGeneesmiddelSoortCodelijst | active | nl | hl7 | sct tho | |||
nictiz.fhir.nl.stu3.zib2015 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20150401000000 | DrugsOfGeneesmiddelSoortCodelijst | retired | nl | fhir sct | ||||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20171231000000 | DrugsOfGeneesmiddelSoortCodelijst | active | nl | fhir sct | ||||
hl7.fhir.us.breast-radiology | R4 | DuctAbnormalityTypeVS | Duct Abnormality Type ValueSet | active | 2022-12 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.14914 | Race Value Set | active | 2024-06 | us | hl7 | oid | ||
de.medizininformatikinitiative.kerndatensatz.prozedur | R4 | mii-vs-prozedur-durchfuehrungsabsicht-snomedct | MII VS Prozedur Durchführungsabsicht [SNOMED CT] | active | 2024-12 | de | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7926 | Number of Cigarettes Smoked per Day (CO) | active | 2019-01 | us | sct tho oid | |||
dk.kip.rkkp.fhir.ig.core | R4 | JaNejUvistIkkeudfoert | Ja / Nej / Uvist / Ikke udført | active | 2022-07 | internal tho | ||||
dk.kip.rkkp.fhir.ig.core | R4 | JaNejIkkefagligrelevant | Ja / Nej / Ikke faglig relevant | active | 2022-09 | tho | ||||
dk.kip.rkkp.fhir.ig.core | R4 | JaNejIkkerelevant | Ja / Nej / Ikke relevant | active | 2022-05 | tho | ||||
dk.kip.rkkp.fhir.ig.core | R4 | JaNejIkkeUdfoert | Ja / Nej / Ikke udført | active | 2022-07 | internal tho | ||||
ans.fr.nos | R4 | JDV-J248-DepartementOM-ROR | JDV_J248-DepartementOM-ROR | retired | 2024-01 | fr | national | |||
ans.fr.nos | R4 | JDV-J167-DepartementOM-EPARS | JDV_J167-DepartementOM-EPARS | retired | 2024-01 | fr | national | |||
ans.fr.nos | R4 | JDV-J84-DepartementOM-RASS | JDV_J84-DepartementOM-RASS | retired | 2024-01 | fr | national | |||
dk.kip.rkkp.fhir.ig.core | R4 | DoedsaarsagLYFO | Dødsårsag (LYFO) | active | 2022-07 | internal tho | ||||
dk.kip.rkkp.fhir.ig.core | R4 | DoedsaarsagCLL | Doedsaarsag [CLL] | active | 2022-07 | internal tho | ||||
dk.kip.rkkp.fhir.ig.core | R4 | DoedsaarsagALD | Dødsårsager [ALD] | active | 2022-05 | internal tho | ||||
dk.kip.rkkp.fhir.ig.core | R4 | DoedsaarsagDAMYDA | Dødsårsager [DAMYDA] | active | 2022-05 | internal tho | ||||
dk.kip.rkkp.fhir.ig.core | R4 | DoedsaarsagSAH | Dødsårsager [SAH] | active | 2022-05 | internal tho | ||||
dk.kip.rkkp.fhir.ig.core | R4 | DosisAKbehDKR | Dosis AK behandling (DKR) | active | 2023-12 | internal | ||||
poc.bonsai.current | R4 | workplace-types | Arbetsplatstyp | active | 2022-02 | |||||
poc.bonsai.current | R4 | nll-reason-for-cancellation | Felregistreringsorsak | active | 2021-11 | |||||
poc.bonsai.current | R4 | nll-designation-use | Typ av term | active | 2021-11 | |||||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.292 | Metabolic syndrome I10 | active | 2023-09 | us | hl7 | icd | ||
hl7.fhir.us.registry-protocols | R4 | STEMIFirstNoted | STEMI or STEMI Equivalent First Noted | active | cic | 2023-11 | us | hl7 | fhir | |
de.dktk.oncology | R4 | ValueSet-onco-core-ValueSet-EcogVS | EcogVS | active | ||||||
hl7.fhir.uv.pharm-quality | R5 | vs-medicine-doseform | Medicine Dose Form EDQM | active | brr | 2024-05 | uv | hl7 | ||
hl7.fhir.uv.ips | R4 | medicine-doseform | Medicine Doseform - IPS | trial-use | 2 | pc | 2025-05 | uv | hl7 | |
hl7.fhir.uv.pharm-quality | R5 | vs-medicine-route-of-administration | Medicine Route of Administration EDQM | active | brr | 2024-05 | uv | hl7 | ||
hl7.fhir.uv.ips | R4 | medicine-route-of-administration | Medicine Route of Administration - IPS | trial-use | 2 | pc | 2025-05 | uv | hl7 | |
idmp.who-umc.org.fhir | R5 | pharmaceuticalForm | EDQM Pharmaceutical Form | active | 2025-06 | uv | ||||
idmp.who-umc.org.fhir | R5 | edqm-AME | EDQM PDF characteristics: Administration Method | active | 2025-06 | uv | internal | |||
idmp.who-umc.org.fhir | R5 | edqm-BDF | EDQM PDF characteristics: Basic Dose Form | active | 2025-06 | uv | internal | |||
idmp.who-umc.org.fhir | R5 | edqm-ISI | EDQM PDF characteristics: Intended Site | active | 2025-06 | uv | internal | |||
idmp.who-umc.org.fhir | R5 | edqm-RCA | EDQM PDF characteristics: Release Characteristics | active | 2025-06 | uv | internal | |||
poc.bonsai.current | R4 | nll-edqm-method | EDQM Administreringsmetod | active | 2021-11 | |||||
poc.bonsai.current | R4 | nll-edqm-route | EDQM Administreringsväg | active | 2021-11 | |||||
basisprofil.de | R3 | ValueSet-edqm-darreichungsform | EDQMDoseForm | draft | hl7 | oid | ||||
dk.kip.rkkp.fhir.ig.core | R4 | EDTAHaemodialyseDNSL | EDTA koder Hæmodialyse (DNSL) | active | 2024-01 | internal | ||||
dk.kip.rkkp.fhir.ig.core | R4 | EDTAPeritonedialyseDNSL | EDTA koder Peritonedialyse (DNSL) | active | 2024-01 | internal | ||||
dk.kip.rkkp.fhir.ig.core | R4 | EDTATransplantationDNSL | EDTA koder Transplantation (DNSL) | active | 2024-01 | internal | ||||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.232 | EGFR Molecular Variants Amivantamab PM | active | 2024-05 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.231 | EGFR Amivantamab Molecular Variants | active | 2024-05 | us | hl7 | loinc | ||
dk.ehmi.terminology | R4 | eer-medcom-message-definition-type-valueset | EHMI Endpoint Register (EER) - MedComMessageDefinitionType Valueset | active | 2025-02 | dk | internal | |||
dk.ehmi.terminology | R4 | eer-messagedefinition-use-context-code-valueset | EHMI Endpoint Register (EER) - UseContextCodeSystem Valueset | active | 2025-02 | dk | tho | |||
dk.kip.rkkp.fhir.ig.core | R4 | EHSVentralHernieLateral | EHS ventral hernie - lateral | active | 2022-07 | internal | ||||
dk.kip.rkkp.fhir.ig.core | R4 | EHSVentralHernieSamlet | EHS ventral hernie - samlet | active | 2023-07 | internal | ||||
dk.kip.rkkp.fhir.ig.core | R4 | EHSVentralHernieMidtlinie | EHS ventral hernie - midtlinie | active | 2022-07 | internal | ||||
dk.kip.rkkp.fhir.ig.core | R4 | EHSVentralHernieType | EHS ventral hernie type | active | 2023-07 | internal | ||||
de.basisprofil.r4 | R4 | EkgLeads | EKG/ECG leads | active | 2025-06 | hl7 | loinc | |||
hl7.eu.fhir.unicom | R5 | legal-status-for-the-supply-vs | EMA SPOR Legal Status for the Supply | draft | 2025-06 | eu | hl7 | |||
dk.kip.rkkp.fhir.ig.core | R4 | EORTC14DPD | EORTC Grad 1-4 (DPD) | active | 2022-07 | internal | ||||
dk.kip.rkkp.fhir.ig.core | R4 | EORTC17DPD | EORTC Grad 1-7 (DPD) | active | 2022-07 | internal | ||||
dk.kip.rkkp.fhir.ig.core | R4 | EORTC17DUGA | EORTC Grad 1-7 (DUGA) | active | 2024-03 | internal | ||||
dk.kip.rkkp.fhir.ig.core | R4 | EORTC24DPD | EORTC Grad 2-4 (DPD) | active | 2022-10 | internal | ||||
de.gematik.epa | R4 | epa-audit-event-agent-type-client-vs | EPA AuditEvent Agent Type Client | active | 2025-05 | de | dcm | |||
de.gematik.epa | R4 | epa-audit-event-agent-type-user-vs | EPA AuditEvent Agent Type User | active | 2025-05 | de | internal tho | |||
who.ddcc | R4 | EUDCCValueSet | EU DCC Allowed Vaccine List (COVID-19) | draft | 2022-09 | uv | who | |||
ema.qrdvalidation | R5 | EUepiAnnexIIqrdcodesVs | EU EPI Annex II document QRD codes value set | active | ||||||
ema.qrdvalidation | R5 | EUepicapqrdcodesVs | EU EPI CAP QRD codes value set | active | ||||||
ema.qrdvalidation | R5 | documentTypeVs | EU EPI Document Type Value Set | active | ||||||
ema.qrdvalidation | R5 | EUepiLabellingqrdcodesVs | EU EPI Labelling document QRD codes value set | active | ||||||
ema.qrdvalidation | R5 | EUepinapmrpdcpqrdcodesVs | EU EPI NAP-MRP-DCP QRD codes value set | active | ||||||
ema.qrdvalidation | R5 | EUepiPackageLeafletqrdcodesVs | EU EPI Package Leaflet document QRD codes value set | active | ||||||
ema.qrdvalidation | R5 | EUepismpcqrdcodesVs | EU EPI SmPC document QRD codes value set | active | ||||||
eu.epi.february2025b | R5 | EUepidocumenttypesVs | 01 Document Type Value Set | active | ||||||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.56 | Early and Limited Stage | active | 2023-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.57 | Early Stage IIB or lower | active | 2023-11 | us | hl7 | ncit | ||
hl7.eu.fhir.idea4rc | R4 | ecog-i4rc | ECOG Performance Status | active | 2025-07 | eu | hl7 | |||
healthdata.be.r4.cbb | R4 | Eating | Eating | draft | sct | |||||
healthdata.be.r4.cbb | R4 | EatingLimitations | EatingLimitations | draft | sct | |||||
nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.11.321--20210412154013 | Echelon_3.2 | active | nl | fhir sct | ||||
IdHIE.0v | R4 | value-set-education-level-id-core | ValueSetEducationLevel (ID Core) | active | 2023-06 | |||||
MyHIE.v4-test | R4 | value-set-education-level-my-core | ValueSetEducationLevel (MY Core) | active | 2023-01 | |||||
dhp | R5 | education-vs | Education levels | draft | 2025-07 | |||||
dk.ehmi.terminology | R4 | eer-messagedefinition-identifer-system-valueset | EHMI Endpoint Register (EER) - MessageDefinitionIdentifierSystem Valueset | active | 2025-02 | dk | internal | |||
hl7.fhir.ee.mpi | R5 | guardian-status | Guardian Status | draft | 2023-12 | ee | hl7 | sct | ||
ee.fhir.terminology | R5 | eestkoste-liik | Eestkoste liik | active | 2025-06 | ee | hl7 | sct | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.7.2--20200901000000 | EetBeperkingenCodelijst | active | nl | hl7 | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.7.2--20171231000000 | EetBeperkingenCodelijst | active | nl | sct | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.6.2--20200901000000 | EetlustScoreCodelijst | active | nl | hl7 | oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.6.2--20171231000000 | EetlustScoreCodelijst | active | nl | oid | ||||
odilab.evo | R4 | VS-HIMI-HEIMI-KBV-FORMULAR-ART | VS_HIMI_HEIMI_KBV_FORMULAR_ART | draft | ||||||
basisprofil.tiplu.de.r4.dev | R4 | TipluDocumentTypeVS | TipluDocumentType - ValueSet | active | 2023-01 | |||||
nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.11.219--20161122103657 | Einde Zwangerschap (verwijsreden) | active | nl | fhir oid | ||||
de.gkvsv.erezeptabrechnungsdaten | R4 | GKVSV-VS-ERP-Leistungserbringertyp | GKVSV_VS_ERP_Leistungserbringertyp | active | 2024-02 | |||||
de.medizininformatikinitiative.kerndatensatz.mtb | R4 | mii-vs-mtb-systemische-therapie-status | MII VS MTB Systemtherapie Status | draft | de | fhir | ||||
de.basisprofil.r4 | R4 | EncounterStatusDe | Encounter Status ValueSet | active | 2025-06 | hl7 | fhir | |||
vcds-ig.euvabeco.net | R5 | ForecastReasons | Forecast reasons for a recommendation | draft | 2025-05 | internal | ||||
hl7.terminology | R5 | action-participant-role | Action Participant Role | draft | 2017-02 | uv | hl7 | fhir | ||
dk.kip.rkkp.fhir.ig.core | R4 | SKSExtraModularDisease | Ekstramedullær sygdom | active | 2022-06 | internal | ||||
hl7.fhir.cl.minsal.eis | R4 | VSEstadoCivil | Estado Civil | active | 2022-01 | cl | hl7 | internal | ||
hl7.terminology | R5 | v3-ElectroOsmosisRoute | ElectroOsmosisRoute | active | 2014-03 | uv | hl7 | tho | ||
hl7.fhir.us.registry-protocols | R4 | ElectrocardiacAbnormalityType | Electrocardiac Abnormality Type | active | cic | 2023-11 | us | hl7 | fhir sct | |
hl7.fhir.us.registry-protocols | R4 | ElectrocardiacAssessmentMethod | Electrocardiac Assessment Method | active | cic | 2023-11 | us | hl7 | fhir sct | |
hl7.fhir.us.registry-protocols | R4 | ElectrocardiacAssessmentResults | Electrocardiac Assessment Results | active | cic | 2023-11 | us | hl7 | fhir sct | |
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.6.3--20200901000000 | EmailSoortCodelijst | active | nl | hl7 | tho | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.6.3--20171231000000 | EmailSoortCodelijst | active | nl | fhir | ||||
healthhub.fhir | R4 | EmployeeIdentifierSystemValueSet | Health Hub Employee Identifier System | active | 2024-09 | dk | oid | |||
healthhub.fhir.dk.core | R4 | EmployeeIdentifierSystemValueSet | Health Hub Employee Identifier System | active | 2024-09 | dk | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.985 | Employment Status | active | 2008-01 | us | sct tho | |||
ans.fr.terminologies | R4 | jdv-hl7-v3-employmentStatusODH-cisis | EmploymentStatusODH | active | 2025-06 | fr | national | tho | ||
dk.kip.rkkp.fhir.ig.core | R4 | HeartAttackSTEMIPosition | Position af STEMI hjertestop | active | 2022-06 | internal | ||||
poc.bonsai.current | R4 | gruppforskrivarkod | Gruppförskrivarkod | active | 2022-02 | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1011 | Data Subtype | active | 2008-01 | us | ||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1012 | Type of Data | active | 2008-01 | us | ||||
hl7.terminology | R5 | v3-ActStatusNormal | ActStatusNormal | active | 2014-03 | uv | hl7 | tho | ||
MyHIE.v4-test | R4 | value-set-encounter-category-my-core | ValueSetEncounterCategory (MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-encounter-category-id-core | ValueSetEncounterCategory (ID Core) | active | 2023-06 | |||||
ca.on.dhdr.r4.v4 | R4 | encounter-class | Encounter Class | active | us | hl7 | tho | |||
ca.on.oh-olis | R4 | encounter.class | EncounterClass | active | hl7 | tho | ||||
laniado.test.fhir.r4 | R4 | encounter-department-type | Encounter Department Type | draft | sct | |||||
fhir.cdc.opioid-cds-r4 | R4 | condition-encounter-diagnosis-category | Encounter Diagnosis Condition Category | active | 2023-05 | us | hl7 | |||
laniado.test.fhir.r4 | R4 | k-huva | k-huva | draft | ||||||
MyHIE.v4-test | R4 | value-set-encounter-rating-my-core | ValueSetEncounterRating (MY Core) | active | 2023-12 | |||||
MyHIE.v4-test | R4 | value-set-visit-type-my-core | ValueSetVisitType (MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-visit-type-id-core | ValueSetVisitType (ID Core) | active | 2023-06 | |||||
MyHIE.v4-test | R4 | value-set-encounter-outcome-my-core | ValueSetEncounterOutcome( MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-encounter-outcome-id-core | ValueSetEncounterOutcome( ID Core) | active | 2023-06 | |||||
MyHIE.v4-test | R4 | value-set-encounter-outcome-reason-my-core | ValueSetEncounterOutcomeReason( MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-encounter-outcome-reason-id-core | ValueSetEncounterOutcomeReason( ID Core) | active | 2023-06 | |||||
MyHIE.v4-test | R4 | value-set-allergy-manifestation-my-core | value-set-allergy-manifestation-my-core | active | 2023-01 | sct | ||||
MyHIE.v4-test | R4 | value-set-encounter-status-my-core | value-set-encounter-status-my-core | active | 2023-01 | fhir | ||||
IdHIE.0v | R4 | value-set-allergy-manifestation-id-core | value-set-allergy-manifestation-id-core | active | 2023-06 | sct | ||||
IdHIE.0v | R4 | value-set-encounter-priority-id-core | value-set-encounter-priority-id-core | active | 2023-06 | tho | ||||
IdHIE.0v | R4 | value-set-encounter-status-id-core | value-set-encounter-status-id-core | active | 2023-06 | fhir | ||||
dk.fhir.ig.kl.common.caresocial | R4 | KLEncounterTypes | KLEncounterTypes | active | 2020-10 | |||||
kl.dk.fhir.term | R4 | KLEncounterTypes | KLKontaktTyper | active | 2024-10 | dk | internal | |||
kl.dk.fhir.core | R4 | KLEncounterTypes | KLKontaktTyper | active | 2023-06 | dk | ||||
smart4health.eu.core | R4 | S4hEncounterTypeSet | S4H encounter type set | draft | 2020-11 | |||||
ca.on.oh.corhealth | R4 | CorHealth61EndocarditisVS | Endocarditis | active | ||||||
hl7.terminology | R5 | v3-EndocervicalRoute | EndocervicalRoute | active | 2014-03 | uv | hl7 | tho | ||
hl7.fhir.us.directory-query | R4 | EndpointConnectionTypeVS | Endpoint Connection Types Value Set | active | 2022-12 | us | hl7 | fhir tho | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | EndpointConnectionTypeVS | Endpoint Connection Types VS | trial-use | fm | 2025-02 | us | hl7 | fhir tho | |
hl7.fhir.us.ndh | R4 | EndpointConnectionTypeVS | Endpoint Connection Types Value Set | trial-use | pa | 2025-07 | us | hl7 | fhir ihe tho | |
hl7.fhir.us.ndh | R4 | EndpointFhirMimeTypeVS | Endpoint FHIR Mimetype Value Set | trial-use | pa | 2025-07 | us | hl7 | ietf | |
hl7.fhir.us.ndh | R4 | EndpointIheSpecificConnectionTypeVS | Endpoint IHE Specific Connection Types Value Set | trial-use | pa | 2025-07 | us | hl7 | ihe | |
hl7.fhir.us.directory-query | R4 | EndpointPayloadTypeVS | Endpoint Payload Type Value Set | active | 2022-12 | us | hl7 | fhir | ||
hl7.fhir.us.davinci-pdex | R4 | EndpointPayloadTypeVS | Endpoint Payload Type Value Set | trial-use | 2 | fm | 2025-06 | us | hl7 | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | EndpointPayloadTypeVS | Endpoint Payload Types VS | trial-use | fm | 2025-02 | us | hl7 | fhir |